The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at 90 hospitals.

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

Consistent and correct use of latex and synthetic polymer condoms and dental dams can decrease the risk of acquiring and transmitting the majority of STBBI, including HIV, HBV, HCV, chlamydia and ...

Bluejay’s lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where ...

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...